Abstract Details
|
Muhammad Azeem, MD
(University of Massachusetts Medical School)
PRESENTER |
No disclosure on file |
| No disclosure on file | |
| Muhammad Nagy, MBBCh, MSc (JFK Neuroscience institute (Neurology Department)) | Dr. Nagy has nothing to disclose. |
| No disclosure on file | |
| No disclosure on file | |
| Nils Henninger, MD, PhD, FANA, FWSO (UMass Memorial Medical Center) | Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Henninger has stock in United Health. Dr. Henninger has stock in Novo Nordisk. Dr. Henninger has stock in Elli Lilly. Dr. Henninger has stock in Kenvue. Dr. Henninger has stock in Voyager. Dr. Henninger has stock in Alnylam. Dr. Henninger has stock in Entrada. The institution of Dr. Henninger has received research support from NIH. Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Verge Genomics. |
| Kate Daniello, MD, FAAN (University of Massachusetts) | Dr. Daniello has nothing to disclose. |